The Relationship between Social Determinants of Health and Neurocognitive and Mood-Related Symptoms in the Primary Brain Tumor Population: A Systematic Review

IF 2.4 Q2 CLINICAL NEUROLOGY

Neuro-oncology practice Pub Date : 2024-03-05 DOI:10.1093/nop/npae016

M. Stockdill, A. King, Morgan Johnson, Z. Karim, D. Cooper, Terri S Armstrong

{"title":"The Relationship between Social Determinants of Health and Neurocognitive and Mood-Related Symptoms in the Primary Brain Tumor Population: A Systematic Review","authors":"M. Stockdill, A. King, Morgan Johnson, Z. Karim, D. Cooper, Terri S Armstrong","doi":"10.1093/nop/npae016","DOIUrl":null,"url":null,"abstract":"\n Social determinants of health (SDOH) impact cancer-related health outcomes, including survival, but their impact on symptoms is less understood among the primary brain tumor (PBT) population. We conducted a systematic review to examine the relationships between SDOH and neurocognitive and mood-related symptoms among the PBT population. PubMed, EMBASE, and CINAHL were searched using PROGRESS criteria (Place of residence, Race/ethnicity, Occupation, Gender/Sex, Religion, Education, Socioeconomic status, Social capital) on March 8th, 2022. Two individuals screened and assessed study quality using the NHLBI Assessment Tool for Observational Cohort and Cross-sectional Studies. Of 3,006 abstracts identified, 150 full-text articles were assessed, and 48 were included for a total sample of 28,454 study participants. Twenty-two studies examined one SDOH; none examined all eight. Four studies measured place of residence, 2 race/ethnicity, 13 occupation, 42 gender, 1 religion, 18 education, 4 socioeconomic status, and 15 social capital. Fifteen studies assessed neurocognitive and 37 mood-related symptoms. While higher education was associated with less neurocognitive symptoms and among individuals with meningioma sustained unemployment after surgery with depressive symptoms, results were otherwise disparate among SDOH and symptoms. Most studies were descriptive or exploratory, lacking comprehensive inclusion of SDOH. Standardizing SDOH collection, reducing bias, and recruiting diverse samples is recommended in future interventions.","PeriodicalId":19234,"journal":{"name":"Neuro-oncology practice","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npae016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Social determinants of health (SDOH) impact cancer-related health outcomes, including survival, but their impact on symptoms is less understood among the primary brain tumor (PBT) population. We conducted a systematic review to examine the relationships between SDOH and neurocognitive and mood-related symptoms among the PBT population. PubMed, EMBASE, and CINAHL were searched using PROGRESS criteria (Place of residence, Race/ethnicity, Occupation, Gender/Sex, Religion, Education, Socioeconomic status, Social capital) on March 8th, 2022. Two individuals screened and assessed study quality using the NHLBI Assessment Tool for Observational Cohort and Cross-sectional Studies. Of 3,006 abstracts identified, 150 full-text articles were assessed, and 48 were included for a total sample of 28,454 study participants. Twenty-two studies examined one SDOH; none examined all eight. Four studies measured place of residence, 2 race/ethnicity, 13 occupation, 42 gender, 1 religion, 18 education, 4 socioeconomic status, and 15 social capital. Fifteen studies assessed neurocognitive and 37 mood-related symptoms. While higher education was associated with less neurocognitive symptoms and among individuals with meningioma sustained unemployment after surgery with depressive symptoms, results were otherwise disparate among SDOH and symptoms. Most studies were descriptive or exploratory, lacking comprehensive inclusion of SDOH. Standardizing SDOH collection, reducing bias, and recruiting diverse samples is recommended in future interventions.

查看原文本刊更多论文

原发性脑肿瘤患者的健康社会决定因素与神经认知和情绪相关症状之间的关系：系统回顾

健康的社会决定因素（SDOH）会影响癌症相关的健康结果，包括生存率，但它们对原发性脑肿瘤（PBT）人群症状的影响却不甚了解。我们进行了一项系统性综述，研究原发性脑肿瘤人群中 SDOH 与神经认知症状和情绪相关症状之间的关系。2022 年 3 月 8 日，我们使用 PROGRESS 标准（居住地、种族/民族、职业、性别/性、宗教、教育、社会经济地位、社会资本）检索了 PubMed、EMBASE 和 CINAHL。两名专家使用国家慢性病和癌症研究所的观察性队列和横断面研究评估工具对研究质量进行了筛选和评估。在确定的 3,006 篇摘要中，对 150 篇全文进行了评估，并纳入了 48 篇文章，研究参与者样本总数为 28,454 人。22 项研究对一种 SDOH 进行了研究；没有一项研究对所有八种 SDOH 进行了研究。4 项研究测量了居住地、2 项种族/民族、13 项职业、42 项性别、1 项宗教、18 项教育、4 项社会经济地位和 15 项社会资本。15 项研究评估了神经认知症状，37 项评估了情绪相关症状。虽然教育程度越高，神经认知症状越少，脑膜瘤患者术后持续失业与抑郁症状也有关联，但在其他方面，SDOH 和症状之间的结果并不一致。大多数研究都是描述性或探索性的，没有全面纳入 SDOH。建议在未来的干预措施中规范 SDOH 的收集、减少偏差并招募不同的样本。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neuro-oncology practice CLINICAL NEUROLOGY-

CiteScore

5.30

自引率

11.10%

发文量

期刊介绍： Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving